MVK Select Exons
New York
Approved
Genes
Conditions
- Hyper-IgD Syndrome
Clinical Utility
- Confirmation of a clinical diagnosis
- To assist in determining the most appropriate therapy, as the response to specific therapeutic modalities depends on the diagnosis
- Recurrence risk Carrier testing in at-risk family members
- Prenatal diagnosis
Lab Method
- Capillary Sequencing
Test Code
216
CPT Codes*
81479x1
ABN Required
No
Turnaround Time**
3 weeks
Preferred Specimen
Alternative Specimen
*The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.
**Reporting times are typical and begin once the sample(s) are received at the GeneDx laboratory, but could be extended in situations outside GeneDx’s reasonable control.
Test Documents
Billing
Targeted Variant Testing